VANGUARD GROUP INC 13D and 13G filings for Utah Medical Products, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-12 6:02 pm Unchanged | 2024-09-30 | 13G | Utah Medical Products, Inc. UTMD | VANGUARD GROUP INC | 181,169 5.210% | 0 (Unchanged) | Filing |
| 2024-11-04 2:00 pm Purchase | 2024-09-30 | 13G | Utah Medical Products, Inc. UTMD | VANGUARD GROUP INC | 181,169 5.210% | 13,479 (+8.04%) | Filing |
| 2023-02-09 11:35 am Sale | 2022-12-30 | 13G | Utah Medical Products, Inc. UTMD | VANGUARD GROUP INC | 167,690 4.620% | -21,883 (-11.54%) | Filing |
| 2022-02-10 08:42 am Purchase | 2021-12-31 | 13G | Utah Medical Products, Inc. UTMD | VANGUARD GROUP INC | 189,573 5.190% | 636 (+0.34%) | Filing |
| 2021-02-10 11:57 am Purchase | 2020-12-31 | 13G | Utah Medical Products, Inc. UTMD | VANGUARD GROUP INC | 188,937 5.190% | 188,937 (New Position) | Filing |